Full Text View
Tabular View
No Study Results Posted
Related Studies
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
This study has been completed.
Study NCT00309712   Information provided by Intermountain Health Care, Inc.

First Received on March 30, 2006.   Last Updated on August 20, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type II Diabetes Mellitus
Mixed Dyslipidemia
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
Dyslipidemias
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
fenofibrate 160 mg and placebo
simvastatin 20 mg and placebo
Additional drug interventions recognized in this trial
Fenofibrate
Simvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Intermountain Health Care, Inc.
Abbott
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services